Kenzi RIBOULET-ZEMOULI

Barcelona-based independent researcher.

Co-founder of the non-profit NORML France, and the think-tank FAAAT.

Human rights-components, ethics, and sustainability of legally-regulated settings related to the use, marketing, and production of controlled plants/products/substances.

Upgrading public action on psychoactive substances:

Resilient policies. Sustainable planet.

Born in France, raised around the Mediterranean and now based in Barcelona (Catalonia, Spain), Kenzi is a French-Algerian multidisciplinary researcher and advocate for sustainable drug policy reforms.

Focused on Action research (the match of scholars and citizens) as a catalyzer for legal and social changes, Kenzi has been particularly involved in studying alternative pathways for Cannabis policy reform, linking international law with local grassroot initiatives. He anchors his work on the ethics, human rights aspects, fair trade components, and criteria of sustainability of legally-regulated use, production and marketing of controlled plants, products or substances.

“Drugs don’t deserve drug policy. What is needed to “control” drugs and reduce harms are sensible healthcare, poverty, social, educational, geopolitical, security and development policies that integrate drug-related factors. But certainly not sui generis drug policies.”

TEXTS

CONFERENCES & STATEMENTS

62nd Commission on Narcotic Drugs

United Nations, Vienna, Austria

14 March 2019

 

Statement to the plenary on item 9(c): International Narcotics Control Board

International Cannabis Policy Conference, Special UN event

United Nations, Vienna, Austria

7 December 2018

 

Cannabis: Next steps for the Commission on Narcotic Drugs.

II Fòrum de Associacions i Clubs de Cànnabis de Catalunya

Universitat Autònoma de Barcelona, Bellaterra, Spain

23 November 2018

 

Actualitat social, política i legal del fenomen dels CSC: De la política internacional a la realitat catalana

Open Session of the 41st meeting of the Expert Committee on Drug Dependence

World Health Organization, Geneva, Switzerland

12 November 2018

 

Statement to the Experts of THE 41 ST MEETING OF THE ECDD

Cultiva HanfKongress

Pyramid, Vienna, Austria

12 October 2018

 

Cannabis within the UN treaties: are changes finally coming?

Cannabis Box Forum

Expogrow, Irún, Spain

15 September 2018

 

REGULACIÓN del CANNABIS al INTERNACIONAL

It’s about the future in patient care – how Cannabis will change medical care

Columbia University Global Center, PARIS, FRANCE

12 SEPTEMBER 2018

 

Access issues: rights, policy & regulation

EUROPEAN INDUSTRIAL HEMP ASSOCIATION 15TH CONFERENCE

COLOGNE, GERMANY

13 JUNE 2018

 

Cannabidiol and Cannabis Related Substances: a Brief Update on WHO/UN Review Process

Société Civile et Politiques Cannabis, Drug Policy Encounters

Geneva, Switzerland

9 June 2018

 

Pieces of history and pathways for the future of Cannabis scheduling internationally

European Youth Event 2018

European Parliament, Strasbourg, FRANCE

2 June 2018

 

Debate. Marijuana: Smells like teen spirit – or escape from reality?

II Congrés CannabMed

CCCB, Barcelona, Spain

13 May 2018

 

UN PUENTE ENTRE LA MEDICINA CANNÁBICA Y LOS PACIENTES: Perspectiva Internacional

International symposium on prospects for development and growth in the rural cannabis cultivating areas of the Moroccan central Riff

Mohammed VI center, Chefchaouen, Morocco

30 April 2017

 

Normalisation du Cannabis: l’instrument indispensable pour des politiques de développement socio-économiques inclusives et durables

SUPPORT TREATY SCHEDULING WORK

Since 2016, the World Health Organization (WHO) has been mandated to assess and update the placement of Cannabis within the International Drug Control Conventions (IDCC). While this process presents an important number of positive opportunities (in particular to clarify and more explicitly exempt hemp and CBD products from the provisions of the IDCC) there are also some risks linked to the complexity of Cannabis plant and its derivatives. This process has also been the occasion of a renewed dialogue between the United Nations system, and the European Union currently undergoing its own revision of hemp and CBD policies.

To support the work of Michael Krawitz and Kenzi Riboulet-Zemouli of the DRCNet Foundation Inc. (independent researchers and policy advocates, with permanent observer status to the United Nations) focused on accompanying the WHO review process and the changes in the scope of IDCC-controls implied, you can donate. Please use the contact form below.

Get in touch!

14 + 14 =